[HTML] scielo.br

[HTML][HTML] Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, AD Rosa… - Jornal Vascular …, 2023 - SciELO Brasil
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …
被引用次数：2 相关文章

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, A De la Rosa… - Jornal Vascular …, 2023 - jvascbras.org
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar… - Jornal vascular …, 2023 - pubmed.ncbi.nlm.nih.gov
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism Uso bem …

K Dah, M Porres-Aguilar, A la Rosa… - Jornal Vascular …, 2023 - europepmc.org
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, A De la Rosa… - Jornal Vascular …, 2023 - jvb.periodikos.com.br
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …
[HTML] scielo.br

[HTML][HTML] Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, AD Rosa… - Jornal Vascular …, 2023 - SciELO Brasil
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, A De la Rosa… - Jornal Vascular …, 2023 - jvascbras.org
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism.

K Dah, M Porres-Aguilar… - Jornal Vascular …, 2023 - search.ebscohost.com
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …
[HTML] nih.gov

[HTML][HTML] Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, A De la Rosa… - Jornal Vascular …, 2023 - ncbi.nlm.nih.gov
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …
[PDF] periodikos.com.br

[PDF][PDF] Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

K Dah, M Porres-Aguilar, A De la Rosa, S Prakash - 2023 - app.periodikos.com.br
Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-
term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The …